Latest Content

Breaking Down the Benefits of Clinical Trial Participation in Cancer Care

May 2nd 2025, 8:00pm

By Dr. Scott T. Tagawa

Video

Dr. Scott T. Tagawa discusses what patients with prostate cancer should know about the potential benefits and risks of participating in a clinical trial.

Smoking Data May Guide Improved Lung Cancer Care and Patient Support

May 2nd 2025, 7:00pm

By Dr. Daniel J. Boffa

Video

Most patients in accredited hospitals had smoking discussions documented, showing key care opportunities and smoking’s impact on treatment outcomes.

Renewal and Healing from Testicular Cancer This May

May 2nd 2025, 5:00pm

By Brian Sluga

Article

After testicular cancer, I’ve learned to guard my mood, seek small joys and embrace healing and renewal with every sunrise this spring.

First Patient Dosed With Azenosertib in Cyclin E1+ Ovarian Cancer

May 2nd 2025, 4:00pm

By Ryan Scott

Article

The first patient with Cyclin E1+ platinum-resistant ovarian cancer has been dosed with azenosertib in part 2a of the phase 2 DENALI clinical trial.

Pretreatment Baseline Screening for Breast Cancer-Related Lymphedema

May 2nd 2025, 3:00pm

By Spencer Feldman

Article

New results from a breast cancer-related lymphedema study show the importance of measuring fluid and body composition before treatment begins.

Dosing of PAS-004 Begins in Patients in MAPK-Driven Tumors

May 2nd 2025, 1:00pm

By Spencer Feldman

Article

Enrollment and initial dosing of PAS-004 at 30 milligrams has begun in three patients with MAPK pathway-driven advanced solid tumors.

Understanding Cancer Changes and Testing: How Testing Guides Your Metastatic Breast Cancer Treatment

May 1st 2025, 9:03pm

By Virginia Kaklamani, MD, DSc

Video

Panelists discuss how testing for specific changes in cancer cells, like ESR1 mutations, can help guide treatment choices for patients with hormone receptor-positive metastatic breast cancer.

Recapping Every FDA Approval Announced in April for Cancer Care

May 1st 2025, 9:00pm

By Ryan Scott

Article

Here is a recap of every FDA approval announced by the regulatory agency in the month of April, spanning various cancer types.

Breaking Down the Stigma and How to Better Understand Rare Blood Cancers

May 1st 2025, 8:00pm

By Dr. Neha Mehta-Shah

Video

Dr. Neha Mehta-Shah discusses ways patients with rare blood cancers, such as lymphoma, can better understand their specific subtype of disease.

Endoscopic Procedure Removes GIST Without Surgery

May 1st 2025, 7:00pm

By Spencer Feldman

Article

A new endoscopic tunneling method, STER, allowed a patient to have a GIST removed without surgery, allowing quicker recovery and fewer complications.

Teddy Bears Are a Good Therapy for Adults With Cancer

May 1st 2025, 5:00pm

By Chester Freeman

Article

Teddy bears offer emotional comfort and connection for adults with cancer, easing anxiety and fostering trust during treatment.

In Vivo CD19 CAR-T Leads to Remission in DLBCL Without Lymphodepletion

May 1st 2025, 4:00pm

By Ryan Scott

Article

A patient with heavily pretreated relapsed/refractory diffuse large B-cell lymphoma achieved complete remission following novel in vivo CD19 CAR-T therapy.

First Patient Dosed in Trial of Ziftomenib for Advanced GIST

May 1st 2025, 3:03pm

By Spencer Feldman

Article

A phase 1 trial has initiated and is investigating treatment with ziftomenib plus Gleevec in advanced GIST following progression on Gleevec.

BRAF Inhibitor Gel Improves Acne-Like Skin Rashes in Colorectal Cancer

May 1st 2025, 1:00pm

By Spencer Feldman

Article

LUT014, a BRAF inhibitor gel, improved acne-like rashes in patients with colorectal cancer undergoing anti-EGFR therapy, according to UCLA researchers.

FDA Completes Review of Hepzato Combo in HER2– Metastatic Breast Cancer

April 30th 2025, 9:00pm

By Ryan Scott

Article

The FDA has completed its 30-day review of an application for Hepzato in combination with standard of care in liver-dominant metastatic breast cancer.